Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01589367
Recruitment Status : Unknown
Verified June 2015 by Seoul National University Hospital.
Recruitment status was:  Recruiting
First Posted : May 1, 2012
Last Update Posted : November 20, 2015
Information provided by (Responsible Party):
Seoul National University Hospital

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : April 2016
  Estimated Study Completion Date : April 2017

Publications automatically indexed to this study by Identifier (NCT Number):